Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bluma Brenner

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2015
HIV-1 Group O Resistance Against Integrase InhibitorsAgnès Depatureaux, Thibault Mesplède, Peter Quashie, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2014
Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistanceIsabelle Hardy, Bluma Brenner, Peter Quashie, et al.
AIDS and Behavior|March 11, 2016
Beyond Condoms: Risk Reduction Strategies Among Gay, Bisexual, and Other Men Who Have Sex With Men Receiving Rapid HIV Testing in Montreal, CanadaJoanne Otis, Amélie McFadyen, Thomas Haig, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2002
Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RTHugues Loemba, Bluma Brenner, Michael A Parniak, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1Dan Turner, Bluma Brenner, Daniela Moisi, et al.
Antiviral Research|October 9, 2002
Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistanceHugues Loemba, Bluma Brenner, Michael A Parniak, et al.
Antiviral Therapy|September 6, 2002
Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and BotswanaHugues Loemba, Bluma Brenner, Michael A Parniak, et al.
AIDS (London, England)|December 13, 2002
A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitorsBluma Brenner, Dan Turner, Maureen Oliveira, et al.
Viruses|April 30, 2021
Phylogenetic Clustering among Asylum Seekers with New HIV-1 Diagnoses in Montreal, QC, CanadaHyejin Park, Bluma Brenner, Ruxandra-Ilinca Ibanescu, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
HIV-1 group O integrase displays lower enzymatic efficiency and higher susceptibility to raltegravir than HIV-1 group M subtype B integraseAgnès Depatureaux, Peter K Quashie, Thibault Mesplède, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2015
HIV-1 Group O Resistance Against Integrase InhibitorsAgnès Depatureaux, Thibault Mesplède, Peter Quashie, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2014
Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistanceIsabelle Hardy, Bluma Brenner, Peter Quashie, et al.
AIDS and Behavior|March 11, 2016
Beyond Condoms: Risk Reduction Strategies Among Gay, Bisexual, and Other Men Who Have Sex With Men Receiving Rapid HIV Testing in Montreal, CanadaJoanne Otis, Amélie McFadyen, Thomas Haig, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2002
Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RTHugues Loemba, Bluma Brenner, Michael A Parniak, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1Dan Turner, Bluma Brenner, Daniela Moisi, et al.
Antiviral Research|October 9, 2002
Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistanceHugues Loemba, Bluma Brenner, Michael A Parniak, et al.
Antiviral Therapy|September 6, 2002
Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and BotswanaHugues Loemba, Bluma Brenner, Michael A Parniak, et al.
AIDS (London, England)|December 13, 2002
A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitorsBluma Brenner, Dan Turner, Maureen Oliveira, et al.
Viruses|April 30, 2021
Phylogenetic Clustering among Asylum Seekers with New HIV-1 Diagnoses in Montreal, QC, CanadaHyejin Park, Bluma Brenner, Ruxandra-Ilinca Ibanescu, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
HIV-1 group O integrase displays lower enzymatic efficiency and higher susceptibility to raltegravir than HIV-1 group M subtype B integraseAgnès Depatureaux, Peter K Quashie, Thibault Mesplède, et al.
Pageof 4